The Olafia Clinic, Oslo University Hospital, Oslo, Norway
The current high prevalence of antibiotic resistance in certain microbes, combined with the additional risk of erroneous use of antibiotics driving further antibiotic resistance, is a global challenge. Currently available technology can identify resistance mutations and guide successful treatment of common sexually transmitted infections. This is particularly pertinent in treating Mycoplasma genitalium and Neisseria gonorrhea infections.
34 IUSTI Congress - European Congres on Sexually transmitted Infections and HIV/AIDS
TAMING THE TIDE of STIs & HIV
Bucharest, September 3-5,